Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory disorder characterized by intractable inflammation specific to the gastrointestinal tract. The precise etiology of IBD remains unknown. Recently, haplotypes of peptidylarginine deiminase type 4 (PADI4) have been identified as the rheumatoid arthritis (RA)-susceptible gene. PADI4 is located at 1p36, which is one of chromosomal loci susceptible for IBD. Then, we examined whether haplotypes and diplotypes of PADI4 are associated with IBD in the Japanese population. We studied haplotypes of PADI4 in 114 patients with UC, 83 patients with CD, and 200 gender-matched healthy controls by PCR-restriction fragment length polymorphism. Frequencies and distributions of haplotypes and diplotypes were compared statistically between patients and controls by logistic regression analysis. The frequency of haplotype 1 was significantly decreased in patients with UC, compared to that in controls (P = 0.037; odds ratio (OR) = 0.702). In contrast, the frequency of haplotype 2 in patients with UC was significantly higher than that in controls (P = 0.003; OR = 1.722). Moreover, of a total of 114 patients with UC, 15 (13.2%) had a diplotype homozygous for haplotype 2, the frequency being significantly higher than in controls (9/200, 4.5%; P = 0.008, OR = 3.215). Our results indicate that Czin 4 haplotype 1 of PADI4 is associated with non-susceptibility to UC, whereas haplotype 2 is susceptible to UC. Thus, it is likely that PADI4 is one of genetic determinants of UC in the Japanese population.
Introduction
Chronic inflammatory bowel disease (IBD) is a multifactorial disorder that is characterized by inflammation specific to the gastrointestinal tract, which results in intestinal malabsorption, immune defense abnormalities, and an exaggerated inflammatory response (1, 2) . Various immune and inflammatory cells, such as lymphocytes, macrophages, and dendritic cells, play important roles in the development and progression of IBD (3) (4) (5) . In addition, bacterial antigens have been implied in the pathological inflammation and may mediate both innate and adaptive responses underlying chronic inflammation (6) (7) (8) . IBD consists of two main subtypes: ulcerative colitis (UC) and Crohn's disease (CD) (1, 2) . Although the precise etiology of IBD remains unknown, both several environmental factors, such as dietary components and microorganisms, and genetic factors may contribute to the occurrence of IBD (6) (7) (8) . In order to identify the genes underlying the etiology of IBD, genome-wide linkage analyses and candidate gene-based association studies have launched and shown possible IBD-susceptibility loci at 16q12 (IBD1), 12q13 (IBD2), 6p13 (IBD3), 14q11 (IBD4), 5q31-q33 (IBD5), 19p13 (IBD6), 1p36 (IBD7), 16q11 (IBD8), 3p21 (IBD9), and other loci (8, 9) .
Recently, peptidylarginine deiminase type 4 (PADI4) located at 1p36 is identified as Czin 6 the rheumatoid arthritis (RA)-susceptible gene (10) . RA is involved in autoimmune diseases, of which pathoetiology is probably similar to UC in a number of respects with not only mechanisms of immune defense abnormalities, such as the elevated production of autoantibody (1, 2) , but also arthritic manifestations, e.g. ankylosing spondylitis and sacroiliitis (11) . Although RA complicated by UC is uncommon, recent report has described the development of UC in patients with RA (12) . More importantly, PADI4 also lies within the IBD-susceptibility locus (IBD7) (8) (9) (10) .
Based on the above findings, we hypothesized that PADI4 could play a role in the pathogenesis of IBD as well as RA. Thus, in this study, we have examined whether haplotypes and diplotypes of PADI4 are associated with IBD in the Japanese population.
Subjects and Methods

Subjects
The study subjects comprised unrelated 114 patients with UC, unrelated 83 patients with CD, and 200 gender-matched, unrelated, healthy volunteers as control. The characteristics of subjects are shown in Table 1 . Age at onset is indicated as the mean ± standard deviation (SD). All participants were Japanese who were randomly recruited from 8 general health Czin 7 clinics in the Nagasaki district of Japan. The study protocol was approved by the Committee for Ethical Issues dealing with the Human Genome and Gene Analysis at Nagasaki University, and written informed consent was obtained from each participant.
The diagnosis of IBD was made on the basis of the endoscopic, radiological, histological, and clinical criteria provided by the WHO Council for International
Organizations of Medical Sciences and the International Organization for the Study of
Inflammatory Bowel Disease (13) (14) (15) . Patients with indeterminate colitis and autoimmune diseases, such as RA, multiple sclerosis, and systemic lupus erythematosus, were excluded from the subjects in this study.
Patients with UC were classified into subgroups according to age at onset (<40 or ≥40 years), extension of lesions (proctitis, left-sided colitis, or pancolitis), disease severity (mild, moderate, or severe) and activity (active or inactive) (Table 1) . Likewise, patient with CD were divided into subgroups according to age at onset (<40 or ≥40 years), localization of lesions (ileal, ileocolonic, colonic, or isolated upper disease), behavior of disease (structuring and penetrating), and disease severity (mild, moderate, or severe) and activity (active or inactive) ( Table 1 ). The extension and location of UC and CD, disease severity of UC and CD, and behavior of CD were stratified in accordance with Montreal classification (16) with Czin 8 slight modification. A high clinical activity index (CAI>5) for UC (17) and a high Crohn's disease activity index (CDAI>150) (18) were regarded as active phase patients.
The source of polymorphisms studied
With regard to haplotypes of PADI4 (GenBank accession number: NT_030584), three single nucleotide polymorphisms (SNPs), padi4_92, padi4_96, and padi4_102, were selected and analyzed, as reported by Caponi et al. (19) . Subsequently, haplotypes were determined to be based on combinations of their three SNPs (10), as shown in Tables 2 and 3, because SNPs in PADI4 lie in a strong linkage disequilibrium block.
Preparation of genomic DNA
Genomic DNA was extracted from whole blood of each subject using the DNA Extractor WB-Rapid Kit (Wako Pure Chemical Industries, Osaka, Japan), according to the manufacturer's protocol.
Determination of three SNPs in PADI4
The three SNPs, padi4_92, padi4_96, and padi4_102, were detected by the polymerase chain 5'-GGAAATACATAAGCCAAAAT-3' for padi4_96 (19) ; forward primer: 5'-CTGGCCCAGGCACCACCAG-3' and reverse primer: 5'-AGGGTTTCGGCAGCTGTGCC-3' for padi4_102 (19) , and 1 U Taq DNA polymerase (Invitrogen Co., Carlsbad, CA). The amplification protocol comprised initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 30 sec, annealing at 60°C for padi4_92, at 52°C for padi4_96, and at 68°C for padi4_102 for 30 sec, extension at 72°C for 30 sec, and final extension at 72°C for 5 min. The 192-base pair (bp) PCR products for padi4_92, 316-bp PCR products for padi4_96, and 400-bp PCR products for padi4_102 were digested at 37°C overnight by restriction enzymes, Msp I (Takara Bio, Shiga, Japan), Hae III (Toyobo, Osaka, Japan), and Rsa I (Toyobo), respectively (19) . The digests were subjected Czin 10 to electrophoresis on a 6% polyacrylamide gel (Nacalai Tesque, Kyoto, Japan) for padi4_92, or on a 2% agarose gel (Nacalai Tesque) for padi4_96 and padi4_102, then stained with ethidium bromide (Nacalai Tesque) and visualized with UV transilluminator (Alpha Innotech, San Leandro, CA).
Statistical analysis
Gender and age values between patients and control subjects were evaluated by chi-square test and unpaired Student's t-test, respectively. Expected allele frequencies were calculated from respective single allele frequencies according to the Hardy-Weinberg equilibrium. The observed and expected allele frequencies were compared by chi-square test with Yates' correction using SNP Alyze 6.01 standard (Dynacom Inc., Yokohama, Japan). The frequencies and distributions of haplotype and diplotype were compared between patients and control subjects by logistic regression analysis. SPSS 15.0 program package (SPSS Japan Inc., Tokyo, Japan) was used for all statistical analyses including calculation of odds ratio (OR) with 95% confidence interval (95% CI). A P value of 0.05 or less than was considered statistically significant. Czin 11 
Results and Discussion
The distributions of genotypes of each SNP on PADI4 in each group corresponded to the Hardy-Weinberg equilibrium (Data not shown). We identified 7 haplotypes composed of 3 SNPs among the subjects in this study (Tables 2 and 3 ). However, the rare frequent haplotypes, Hap 5, Hap 6, and Hap 7, were excluded in Tables 2 and 3 . The frequencies and distributions of haplotypes in our study population corresponded to that in previous studies on association with RA in other Japanese populations (10, 20) . These results imply that the population studied had a homogeneous genetic background.
The frequency of haplotype 1 was significantly decreased in patients with UC, compared to that in control subjects (P = 0.037; OR = 0.702) ( Table 2) . While, the frequency of haplotype 2 was significantly increased in patients with UC, compared to that in control subjects (P = 0.003; OR = 1.722) ( Table 2 ). However, there were no differences in the frequency of haplotypes between patients with CD and control subjects (Tables 3). With regard to genotype, referred to as diplotype, of PADI4, 12 diplotypes composed of 7 haplotypes were identified (Tables 4 and 5 Table 4 ), the frequency being significantly higher than in control subjects (9/200, 4.5%; P = 0.008, OR = 3.215) ( Table 4 ). In contrast, although statistical analysis did not show to be significant, it was a tendency that the frequency of UC patients possessing haplotype 1 homozygosity (Hap 1/1 in Table 4 ) was lower than that of control subjects (34/114, 29.8% vs. 81/200, 40.5%; P = 0.060, OR = 0.624)( Table 4 ). Thus, this is the first report on the association of PADI4 haplotypes as well as diplotypes with IBD.
Moreover, the frequency of another diplotype heterozygous for haplotype 1 and haplotype 4 (Hap 1/4 in Table 5 ) in CD was significantly lower than that in Control (3/83, 3.6% vs. 23/200, 11.5%; P = 0.048, OR = 0.289) ( Table 5 ). With respect to CD, it remains to be confirmed why the diplotype, Hap 1/Hap 4 is associated with non-susceptibility to CD. It is one of the possibilities that these CD patients might become complicated by UC in the future, since pathoetiology of certain CD patients would be closely similar to that of UC patients in spite of unknown molecular mechanisms (21) .
Again, we analyzed the distributions of haplotypes and diplotypes of PADI4 among UC and CD subgroups (Tables 6 and 7 ). There were no significant differences in frequencies of the haplotypes and diplotypes among the subgroups of each IBD subtype.
PDAI enzymes post-translationally catalyze the conversion of arginine residues into Czin 13 citrulline (22) . Citrullinated epitopes are involved in a peptide linkage and are the most specific targets of RA-related autoantibodies (23) (24) (25) . In fact, anti-cyclic citrullinated peptides (anti-CCPs) antibody has been specifically observed in the sera of RA patients and their presence is a useful diagnostic marker for RA (26) . Suzuki and colleagues have identified that a haplotype (haplotype 2) of PADI4 on IBD locus at 1p36 was closely associated with susceptibility to RA (10) . PADI4 mRNA from the susceptible haplotype 2 was significantly more stable than that from non-susceptible alleles (10) Asian studies in Japan and Korea (10, 20, 32) have shown a close correlation between the Czin 15 PADI4 haplotypes and RA, but not in Caucasian RA patients (33) (34) (35) . Inversely, mutations of the caspase activating recruitment domain 15/nucleotide oligomerization domain 2 gene (CARD15/NOD2) at 16q12 (IBD1 locus) were associated with Crohn's disease in the Caucasian, but not in the Japanese (36) (37) (38) (39) . These findings may be due to different genetic background between the races. Even if there is a difference in the molecular mechanism of the pathogenesis of UC between Caucasian and Japanese patients, our results suggest that PADI4 may be one of genetic determinants of UC in the Japanese population, or that another new UC-determinant gene except PADI4 may exist near the PADI4 locus at 1p36 (IBD7 locus). P<0.01, as compared with controls* and CD**, ***, number of the affected patients. Unknown 0 (0.0) 2 (100.0) 0 (0) 0 (0) 0 (0) 2 Upper 0 (0) 0 (0) 1 (100.0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 Unknown 0 (0) 0 (0) 0 (0) 0 (0) 1 (100.0) 0 (0) 0 (0) 0 (0) 1
Tables
